课题基金 / 基金详情

SYNTHETIC STUDIES RELATED TO CANCER RESEARCH & TREATMENT

SYNTHETIC STUDIES RELATED TO CANCER RESEARCH & TREATMENT
与癌症研究相关的综合研究
批准号:
6120212
负责人:
PAUL A WENDER
金额:
$0.55万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2000-02-29

项目摘要

项目成果

PAUL A WENDER的其他基金

相似基金

相关文献

中文摘要
翻译
本提案描述了一个全面的方案,涉及
英文摘要
This proposal describes a comprehensive program involving synthetic, mechanistic, biological, and computer modeling studies directed at the elucidation of the mode of action of demonstrated and of potential cancer chemotherapeutic agents, at the rational design and development of new classes of antitumor agents, and at the development of fundamentally new methodology and strategies for the synthesis of such agents. Five projects are proposed for investigation. A major continuation study will be directed at neocarzinostatin chromophore, the recently identified, structurally unprecedented, biologically active subunit of neocarzinostatin (NCS), a drug used in human cancer chemotherapy. Efforts will focus on determining the molecular basis for the antitumor activity of NCS, on establishing the basis for its DNA cleavage selectivity, on the utilization of this information in the rational design of new antitumor agents, and on the synthesis of simplified analogues and biological probes needed in support of these studies. A second major project is focussed on dynemicin A (Dyn A), an exciting new chemotherapeutic lead exhibiting significant in vitro and in vivo antitumor activity. Attention will be directed at the mechanism of activation of Dyn A, at the rational design and development of new Dyn A analogues, at the structural basis for its DNA lesion selectivity, and at an examination of a potentially biomimetic approach to its unprecedented structure. A third project is directed at the development of fundamentally new classes of DNA-cleaving agents and potential cancer chemotherapeutics that are designed to function by the transition metal, photochemical, and torsional induction of diradical formation. A fourth major effort is focussed on taxol, a compound whose recent, impressive clinical performance is likely to result in its imminent approval for use in cancer chemotherapy. This study is directed at the development of practical approaches to taxol analogues and at the elucidation of the structural requirements for taxol's activity. A final project entails completion of studies on the synthesis of aplysiatoxin. Overall, this research program is expected to be of significant value in chemistry, biology, and medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS: POTENTIAL ANTI AIDS DRUG DVMT
SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS
SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS: POTENTIAL ANTI AIDS DRUG DVMT
SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS: POTENTIAL ANTI AIDS DRUG DVMT
海外基金